Replies to post #331800 on Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

Your post was spot on.

To date we have had ample PRs that show the remarkable viral load reduction Brilacidin provides.

The ABSSSI trial showed the remarkable antibacterial properties of Brilacidin in its comparison to Daptomyacin in the trial.

We have had excellent results in a human lung tissue test at the RBL and this is what Dr. Ahmed should hone in on and also be able to generalize (as our stockholder will point out) how these results lead to very high expectations for Brilacidin to be able to address ALL lung issues to include COPD/Asthma/Bronchitis.

So while she will most likely be interested in the pulmonary benefits that Brilacidin has shown, she cannot help but be blown away by the additional benefits it has, benefits that she has not seen from any other drug to date.

She should become one of the biggest spokeswomen for this new arm of medicine, defensin mimetics, as she may be the first person to really promote it to the general public. Would be a major oversight to her brand not to become associated closely with making this wonder drug known to the general public. The same as the GMU RBL will gain massive respect by its early work with B-CV.

I don't think ANY doctor has to be sold on Brilacidin, it sells itself thru the tests and human trials already done, the SI that went thru the ceiling, and its safety profile.

Now if a stockholder can make contact with such a noted doctor, what does that lead to the possible contacts Dr. DeGrado is making thru the upper echelons of medicine in finally being able to bring his "Baby", his "Nobel Prize Baby", to their attention? I would love to know what has been keeping him busy in addition to helping set up the human trial for B-CV. Does anyone believe that the test data to date has not drawn the attention of ALL areas of government that deal w/ medicine to include BARDA, DOD, etc?

I was shocked we didn't get a good PR after election day. Hope the upcoming week starts a new trend in big news because we have to be getting close to human trial kickoff. I hope we start priming the pump with major media spotlighting Brilacidin so the test results expectations, interim data, and final data results lead to Brilacidin explosion in the CV discussion and aid in getting B into EUA as soon as possible, not to mention kick off massive production in facilities standing by for the expected orders.